Urolog. pro Praxi, 2004; 2: 64-66

Ženská sexuální dysfunkce

MUDr. Libor Zámečník, prof. MUDr. Jan Dvořáček DrSc
Urologická klinika 1. LF UK a VFN Praha

Keywords: female sexual dysfunction, pelvic pain, arousal.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zámečník L, Dvořáček J. Ženská sexuální dysfunkce. Urol. praxi. 2004;5(2):64-66.

Ženská sexuální dysfunkce (ŽSD) je onemocnění s poměrně vysokou prevalencí. Její výskyt závisí nejen na věku a omezuje podstatné části postižených žen kvalitu života. Jako multikauzální a multidimenzionální problém zahrnuje jak biologické, tak psychologické a interpersonální faktory. Poruchy jsou děleny do oblasti sexuální touhy, vzrušení, prožívání orgazmu a výskytu bolesti. Autoři shrnují údaje o výskytu, diagnostice a terapii tohoto onemocnění.

FEMALE SEXUAL DYSFUNCTION

Female sexual dysfunction (FSD) is a disease with relatively high incidence in the community. Its incidence in not only age-dependent and it limits life quality of significant proportion of affected women. Dysfunction, as a multicausal and multi­dimensional problem, comprises both biological, psychological and interpersonal factors. Disorders are listed according to a sexual desire, arousal, experiencing an orgasm and pain incidence. Authors summarize data on incidence, diagnosis and therapy of this disease.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994: 493-518.
    2. Berman JR, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology, 1999; 54: 385-391. Go to original source... Go to PubMed...
    3. Berman JR, Berman LA, Lin H, et al. Effect of sildenafil on subjective and physilogic parameters of the sexual response in women with sexual arousal disorder. J. Sex. Marital. Ther., 2001; 27: 411-420. Go to original source... Go to PubMed...
    4. Derogatis LR., Melisarotos N. The DSFI: a multidimensional measure of sexual functioning. Sex. Marital. Ther., 1979; 5: 244. Go to original source... Go to PubMed...
    5. Kaplan HS. The new sex therapy: active treatment of sexual dysfnction. New York: Brunner/Mazel, 1974. Go to original source...
    6. Laumann E, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA, 1999; 281: 537-544. Go to original source... Go to PubMed...
    7. Masters EH, Jonson VE. Human sexual response. Boston: Little Brown 1996.
    8. Mazer NA, Leiblum SR, Rosen RC. The Brief Index of Sexual Functioning for Women (BISF-W): a new scoring algorithm and somparison of nonnative and surgically menopausal populations. Menopause, 2000; 7: 350-362. Go to original source... Go to PubMed...
    9. Moynihan R. The making of a disease: female sexual dysfunction. BMJ, 2003; 326: 45-47. Go to original source... Go to PubMed...
    10. Pacík D, Holtgrewe HL. Sexuální dysfunkce u mužů a žen - role urologa. Urol. listy, 2003; 2: 5-19.
    11. Rosen R, Brown C, Heiman J, Leiblum S, et al. The index of female sexual function (FSFI): a multidimensional self report instrument for the assessment of female sexual function. Sex. Marital. Ther., 2000; 26: 191-208. Go to original source... Go to PubMed...
    12. Rosen RC, Phillips NA, Gendrano N. Oral phentolamine and female sexual arousal disorder: a pilot study. J. Sex. Marital. Ther, 1999; 25: 137-144. Go to original source... Go to PubMed...
    13. Shen WW, Urosevich Z, Clayton DO. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J. Reprod. Med., 1999; 44: 535-542. Go to PubMed...
    14. Spector I, Carey M. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch. Sex. Behav., 1990; 19: 389-408. Go to original source... Go to PubMed...
    15. Tarcan T, Park K, Goldstein I, et al. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J.Urol., 1999; 161: 940-944. Go to original source... Go to PubMed...
    16. Tylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual functioning: psychometric evaluation of the Brief Index of Sexual Function for Women (BSFI). Arch. Sex. Behav. 1994; 23: 627. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.